JP2014532710A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532710A5
JP2014532710A5 JP2014540070A JP2014540070A JP2014532710A5 JP 2014532710 A5 JP2014532710 A5 JP 2014532710A5 JP 2014540070 A JP2014540070 A JP 2014540070A JP 2014540070 A JP2014540070 A JP 2014540070A JP 2014532710 A5 JP2014532710 A5 JP 2014532710A5
Authority
JP
Japan
Prior art keywords
composition
use according
family
genus
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014540070A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532710A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/063008 external-priority patent/WO2013067146A1/en
Publication of JP2014532710A publication Critical patent/JP2014532710A/ja
Publication of JP2014532710A5 publication Critical patent/JP2014532710A5/ja
Pending legal-status Critical Current

Links

JP2014540070A 2011-11-04 2012-11-01 健康を促進するための胃腸細菌を調節する方法及び組成物 Pending JP2014532710A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161555800P 2011-11-04 2011-11-04
US61/555,800 2011-11-04
PCT/US2012/063008 WO2013067146A1 (en) 2011-11-04 2012-11-01 Methods and compositions for modulating gastrointestinal bacteria to promote health

Publications (2)

Publication Number Publication Date
JP2014532710A JP2014532710A (ja) 2014-12-08
JP2014532710A5 true JP2014532710A5 (enExample) 2015-12-17

Family

ID=48192757

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014540070A Pending JP2014532710A (ja) 2011-11-04 2012-11-01 健康を促進するための胃腸細菌を調節する方法及び組成物

Country Status (11)

Country Link
US (1) US20150209383A1 (enExample)
EP (1) EP2773357A4 (enExample)
JP (1) JP2014532710A (enExample)
KR (1) KR20140093252A (enExample)
CN (1) CN104159588A (enExample)
AU (1) AU2012332491A1 (enExample)
BR (1) BR112014010660A2 (enExample)
CA (1) CA2854398A1 (enExample)
IN (1) IN2014CN04055A (enExample)
MX (1) MX2014005433A (enExample)
WO (1) WO2013067146A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201312713D0 (en) * 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
CN107708714B (zh) * 2015-04-14 2022-07-22 普梭梅根公司 用于内分泌系统状况的微生物组来源的诊断和治疗的方法及系统
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
GB201519088D0 (en) * 2015-10-28 2015-12-09 Metabogen Ab The use of bacteria formulations
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
US10398745B2 (en) 2016-01-26 2019-09-03 Fujifilm Corporation Agent for reducing the number of intestinal bacteria, food, and pharmaceutical product
EP3431090A4 (en) * 2016-03-14 2020-04-15 B Food Science Co., Ltd. PROLIFERATIVE AGENT FOR FAECALIBACTERIUM BACTERIA
US10799540B2 (en) * 2016-09-06 2020-10-13 Bgi Shenzhen Faecalibacterium longum and application thereof
US12514897B2 (en) 2017-06-02 2026-01-06 Goodgut S.L. Grape skin for use in the treatment of dysbiosis
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
EP3466417A1 (en) * 2017-10-04 2019-04-10 Sorbonne Université Compounds for the prevention and treatment of glucose intolerance related conditions and obesity
EP3723775A4 (en) 2017-12-15 2022-04-13 Solarea Bio, Inc. MICROBIAL COMPOSITIONS AND METHODS OF TREATING TYPE 2 DIABETES, OBESITY AND METABOLIC SYNDROME
CN109998112B (zh) * 2017-12-22 2024-05-14 奥地利商艾尔柏有限公司 红蝽杆菌纲促进肠道健康的用途
WO2019158546A1 (en) * 2018-02-14 2019-08-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Polydextrose for the treatment of inflammatory diseases
WO2019216815A1 (en) * 2018-05-09 2019-11-14 Carbiotix Ab Method for measuring and improving gut health
WO2019227418A1 (zh) * 2018-05-31 2019-12-05 深圳华大生命科学研究院 一种组合物及其应用
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
WO2020051379A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
ES2763874B2 (es) * 2018-11-30 2020-10-13 Consejo Superior Investigacion Phascolarctobacterium faecium para su uso en la prevencion y tratamiento de la obesidad y sus comorbilidades
JP7624449B2 (ja) * 2019-10-07 2025-01-30 シオルタ・セラピューティクス,インコーポレイテッド 治療用医薬組成物
KR102174095B1 (ko) * 2019-12-11 2020-11-05 주식회사 에이치이엠 신규한 엔테로코커스 패시움 hem 200 균주, 및 상기 균주 또는 이의 배양물을 포함하는 장내 환경 개선용 조성물
CA3175308A1 (en) * 2020-03-13 2021-09-16 Fitbiomics Inc. Probiotic compositions for improving human health and athletic performance
JP7824034B2 (ja) * 2020-04-16 2026-03-04 サンスター株式会社 フィーカリバクテリウム属細菌増殖用組成物、酪酸産生増加用組成物、及び腸内環境改善用組成物
EP4333644A1 (en) * 2021-05-06 2024-03-13 Société des Produits Nestlé S.A. Compositions and methods using at least one of inositol, erythritol or sorbitol to enhance growth of faecalibacterium prausnitzii
EP4436407A1 (en) 2021-11-22 2024-10-02 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0394655A (ja) * 1989-09-06 1991-04-19 Otsuka Pharmaceut Co Ltd 栄養補給用組成物
JP4328473B2 (ja) * 2001-04-09 2009-09-09 雪印乳業株式会社 肥満予防改善飲食品
FI20020078A7 (fi) * 2002-01-15 2003-07-16 Danisco Immuunijärjestelmän stimulointi polydextroosilla
JP2003334025A (ja) * 2002-05-15 2003-11-25 Toyo Shinyaku:Kk 健康食品
DK1530642T3 (da) * 2002-08-06 2010-03-08 Danisco Brug af lactobacillus til fremstilling af exopolysaccharider i fødevarer og farmaceutiske sammensætninger
GB0302872D0 (en) * 2003-02-10 2003-03-12 Univ Liverpool Treatment of inflammatory bowel disease
WO2008147798A2 (en) * 2007-05-23 2008-12-04 Tate & Lyle Ingredients Americas, Inc. Edible composition comprising a slowly digestible or digestion resistant oligosaccharide composition
GB0903016D0 (en) * 2009-02-23 2009-04-08 Univ Gent Method for alleviating intestinal problems and novel bacterial strains therefor
WO2010129839A1 (en) * 2009-05-07 2010-11-11 Tate & Lyle Ingredients France SAS Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans

Similar Documents

Publication Publication Date Title
JP2012532093A5 (enExample)
JP2010195825A5 (enExample)
JP2009537554A5 (enExample)
JP2021535175A5 (enExample)
Zhao et al. Advanced development in analysis of phytochemicals from medicine and food dual purposes plants used in China
WO2014085453A3 (en) Small molecule lxr inverse agonists
BR112012015637A2 (pt) "macarrão instantâneo frito em óleo contendo ferro e seu processo de preparação"
BRPI1015300A2 (pt) "composição nutricional compreendendo um extrato de maçã e reduzindo os sintomas de alegria a alimentos, especialmente em crianças"
WO2011031166A3 (en) Fish feed
JP2011504921A5 (enExample)
HRP20191356T1 (hr) Fitoegdizoni, namijenjeni upotrebi u poboljšavanju kvalitete mišića pretilih i sarkopeničnih sisavaca
Sun et al. Processing mechanism of Epimedium fried with suet oil based on absorption and metabolism of flavonoids
HRP20180620T1 (hr) Liječenje napadaja vrućine tijekom menopauze ropinirolom i tizanidinom
CN104689208A (zh) 一种用于健胃护肝的中药组合物
SG10201501606VA (en) Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders
WO2009108067A3 (en) Fatty acid derivatives for use in the prevention and treatment of hsmi
HRP20161166T1 (hr) Tapentadol za uporabu u liječenju sindroma iritabilnog crijeva
Arzate Martinez Study to impulse exportable offer of Mexican processed products to Midwest of the United States
陈雪军 et al. The Brave Boys
WO2015026708A3 (en) Amelioration of the effects of friedriech's ataxia
CN302205230S (zh) 糖食
TH45603S1 (th) ผ้าอนามัย
CN301581846S (zh) 蛋糕柜
TH114342S (th) ผ้าอนามัย
TH114343S (th) ผ้าอนามัย